Reinventing Biotech’s Business Model: The Photo Gallery

4/4/12Follow @xconomy

(Page 17 of 24)

NEXT IMAGE>>
Reinventing Biotech’s Business Model— Kevin Starr of Third Rock Ventures (left) and John Maraganore of Alnylam Pharmaceuticals listened from the back to what others had to say, before they came up for the closing keynote chat.
Photo by Curt Woodward

Currently on Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 previous page
  • R. Jones

    When you talk about having enough former company T-shirts to build a quilt, you are really talking about enough soul crushing layoffs to kill ones desire to continue pursuing a career in this industry. We’re talking about a huge quilt that represents the loss of billions of dollars.

  • R. Jones

    Quip: a witty or funny observation or response usually made on the spur of the moment.

  • Pingback: Virtual Biotech Companies: Built on Solid Bedrock or Unstable Landfill? | Xconomy